Drugs not selected for Medicare price negotiation nearly doubled - report
The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...
Expanded research on COPD and metabolic syndrome would advance patient-centered care, expert argues
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
News Medical on MSN17h
Addressing COPD and metabolic syndrome requires comprehensive research efforts
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Drugs not selected for Medicare negotiations saw prices nearly double - report
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
List prices for the 25 top Medicare Part D drugs not currently selected for Medicare drug price negotiation have increased by an average of 98 percent—or nearly doubled—since they first entered the ...
First for Women on MSN11h
Doctors Reveal the Best Cold Medicine for Adults Based on Your Symptoms
When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...
Becker's Hospital Review14h
2025's most anticipated 2025 drug approvals: GoodRx
Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.
Lupin gets USFDA nod for generic cystic fibrosis treatment medicine
India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...